CASI Pharmaceuticals, Inc.·4

Sep 24, 4:04 PM ET

Zhang Larry 4

4 · CASI Pharmaceuticals, Inc. · Filed Sep 24, 2019

Insider Transaction Report

Form 4
Period: 2019-09-20
Zhang Larry
President, CASI China
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2019-09-20200,000200,000 total
    Exercise: $3.35Exp: 2029-09-20Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]The stock options were granted on September 20, 2019 and vest as follows: 25 percent on each of the first, second, third and fourth anniversaries of the date of grant.

Documents

1 file
  • 4
    tv529990_4.xmlPrimary

    OWNERSHIP DOCUMENT